Skip to main content

Cytosorbents Corp

CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001175151

In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Cytosorbents Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CTSO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7860−18
Shares15.5M14.9M−634.2K (−4.1%)
Value$33.9M$20.7M−$13.2M (−38.9%)

New holders (3)

Institutions that held Cytosorbents Corp at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CTSO in Q3 2022
InstitutionSharesValue% of portfolio
Brown Brothers Harriman & Co601$1.00K0.00%
Tower Research Capital LLC (TRC)958$1.00K0.00%
Ronald Blue Trust, Inc.218$00.00%

Sold out (21)

Institutions that held Cytosorbents Corp at the end of Q2 2022 and filed for Q3 2022 without it.